Target intelligence / Profile preview

Immune system activation via cytokine secretion

Molecular classification
Other (multicellular process, not a molecule or protein)
01

Overview

Immune system activation via cytokine secretion refers to the process by which immune cells such as macrophages, dendritic cells, neutrophils, mast cells, and lymphocytes secrete cytokines—small soluble proteins that act as intercellular messengers—to coordinate and amplify the body's defenses against infection, injury, and disease. Cytokines bind to specific receptors on immune cells, triggering intracellular signaling cascades that regulate inflammation, cell growth, differentiation, survival, and immune modulation. This process is central to both innate and adaptive immunity; dysregulation can lead to pathological conditions such as autoimmune disorders, chronic inflammation, allergies, and increased susceptibility to infection. Because "immune system activation via cytokine secretion" is a process and not a single molecule, it cannot be targeted directly; therapeutic agents instead target specific cytokines, their receptors, or intracellular signaling pathways.

Other names
cytokine secretionimmune activation by cytokinescytokine-mediated immune response
02

Mechanism of action

For drugs acting on this process in general: immunosuppression (by inhibiting cytokine signaling), immune stimulation (by enhancing cytokine action). Mechanisms are specific to cytokine blockers or cytokine mimetics (e.g., anti-TNF, anti-IL-6, recombinant interferons).

03

Biological functions

Immune responseInflammationSignal transductionCell-cell communicationActivation of innate and adaptive immunity
04

Disease associations

InflammationInfectionCancer (via immunomodulation)Autoimmune diseaseAllergiesImmune deficiency (dysregulated secretion)
05

Safety considerations

Cytokine release syndrome (CRS)Excessive immunosuppression or immune activationRisk of infectionOff-target inflammation
06

Biomarkers

Circulating cytokine levels (e.g., IL-6, TNF, IL-1β)C-reactive protein (CRP) (as a downstream marker)Soluble cytokine receptor levels

Beyond the preview

Go deeper on Immune system activation via cytokine secretion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system activation via cytokine secretion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call